세계의 일회용 의료기기 재처리 시장 보고서 : 기기 유형, 용도, 최종 용도, 지역별(2025-2033년)

The global single-use medical device reprocessing market size reached USD 906.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,533.6 Million by 2033, exhibiting a growth rate (CAGR) of 12.1% during 2025-2033. The rising prevalence of chronic disorders, along with the increasing number of surgical procedures, and quality control methods, and the growing focus on sustainability and reducing medical waste are some of the major factors propelling the market.

Single-use medical device reprocessing is a practice within the healthcare industry aimed at mitigating costs and reducing environmental waste by collecting, cleaning, disinfecting, and refurbishing medical devices that are designed and labeled for single-use. These devices, after appropriate processing, are then reintroduced into the medical setting for subsequent patient use. This approach has gained attention due to its potential to lower expenses associated with medical equipment procurement while also addressing concerns regarding the ecological impact of disposable medical items. The process typically involves rigorous steps to ensure the safety and efficacy of reprocessed devices. Devices are collected and sorted based on their suitability for reprocessing. They then undergo a series of meticulous procedures, including cleaning, disinfection, inspection, testing, and sterilization.

The rising prevalence of chronic disorders, along with the increasing number of surgical procedures, is driving the global market. Moreover, the growing focus on sustainability and reducing medical waste has led to increased interest in reprocessing single-use devices. Reprocessing helps minimize the environmental impact of healthcare by reducing the volume of medical waste that ends up in landfills or incinerators. Furthermore, regulatory agencies in various countries have provided guidelines and approvals for the safe reprocessing of certain single-use medical devices. These regulations support the growth of the reprocessing market by ensuring that reprocessed devices meet stringent safety and quality standards. Ongoing advancements in reprocessing technologies and techniques have improved the effectiveness and safety of the process. These advancements include better cleaning, sterilization, and quality control methods, making reprocessed devices more reliable for clinical use. Also, the establishment of standards and regulations for reprocessing single-use devices has contributed to the growth of the market. Clear guidelines provide healthcare facilities with confidence in the safety and effectiveness of reprocessed devices.

Single-Use Medical Device Reprocessing Market Trends/Drivers:

Cost Containment and Budget Pressures

In an environment of rising healthcare expenditures and financial constraints, hospitals and clinics are seeking innovative ways to maximize resource utilization without compromising patient care. Single-use medical devices are often discarded after a single patient use, leading to significant recurring expenses for replacements. Reprocessing these devices provides an avenue for substantial cost savings, as the refurbished devices can be reintroduced into the clinical setting at a fraction of the cost of new ones. This strategy not only reduces procurement expenses but also contributes to operational efficiency by curtailing the need for frequent supply replenishment. By reallocating funds saved through reprocessing to other critical areas of patient care and infrastructure enhancement, healthcare institutions can alleviate financial pressures while maintaining high standards of medical service delivery.

Environmental Sustainability and Waste Reduction

The healthcare sector generates a significant amount of medical waste, much of which comes from single-use medical devices. These disposables contribute to the accumulation of non-biodegradable materials in landfills, potentially causing environmental harm. Reprocessing offers a solution to this concern by extending the lifespan of these devices through thorough cleaning, disinfection, and sterilization. By reusing reprocessed devices, healthcare facilities can significantly decrease the volume of medical waste generated, promoting a more ecologically responsible approach to medical care. This aligns with the broader societal shift towards environmentally conscious practices and positions healthcare institutions as responsible stewards of both patient health and the environment. As regulatory bodies and patient populations increasingly prioritize sustainability, the adoption of single-use medical device reprocessing becomes a logical choice for healthcare providers looking to reduce their ecological footprint.

Regulatory Support and Technological Advancements

Regulatory agencies, recognizing the potential benefits of reprocessing when conducted with stringent quality controls, have established guidelines and standards to ensure patient safety. As these regulations evolve to ensure the efficacy of reprocessed devices, healthcare facilities are more inclined to incorporate reprocessing into their practices, augmenting the market growth. Moreover, technological advancements have transformed the reprocessing landscape. Innovations in cleaning agents, disinfection methods, and sterilization technologies have enabled more effective removal of contaminants, rendering reprocessed devices comparably safe and reliable as new ones. These advancements also contribute to enhanced quality assurance, reducing the likelihood of adverse events. The marriage of regulatory support and technological progress enhances the credibility of single-use medical device reprocessing, fostering trust among healthcare providers and encouraging broader adoption.

Single-Use Medical Device Reprocessing Industry Segmentation:

Breakup by Device Type:

Class I Devices

Laparoscopic Graspers

Scalpels

Tourniquet Cuffs

Other Class I Devices

Class II Devices

Pulse Oximeter Sensors

Sequential Compression Sleeves

Catheters and Guidewires

Other Class II Devices

Class II devices dominate the market

Class II devices encompass a diverse range of medical instruments that pose a moderate to high risk to patients. These devices often require a more complex reprocessing process due to their intricate designs, various components, and critical functionalities. Class II devices are widely utilized across multiple medical specialties, including cardiology, orthopedics, and gastroenterology. This broad usage translates into a higher volume of devices that can be targeted for reprocessing. Furthermore, the cost implications of Class II devices play a pivotal role. Several devices are expensive to procure, and their disposability contributes significantly to healthcare expenditures. As healthcare providers face mounting pressure to optimize budget allocation, the potential for cost savings through reprocessing becomes particularly attractive. The reprocessing of Class II devices offers a practical solution to mitigate financial burdens while still adhering to stringent quality and safety standards.

Breakup by Application:

General Surgery

Anesthesia

Arthroscopy and Orthopaedic Surgery

Cardiology

Gastroenterology

Gynaecology

Urology

Others

General surgery encompasses a wide array of procedures that address a range of conditions, from routine to complex. This diversity in surgical interventions contributes to the substantial size of the general surgery application segment within the reprocessing market. Single-use devices utilized in general surgery procedures, such as endoscopic tools, laparoscopic instruments, and trocars, are often costly, driving up healthcare expenditures. As hospitals and surgical centers face mounting financial pressures, reprocessing these devices becomes an attractive strategy to control costs without compromising patient safety.

On the other hand, cardiology procedures, ranging from diagnostic angiography to complex interventions, such as angioplasty and stent placement, heavily rely on a variety of single-use medical devices. These devices, often intricate and specialized, contribute to the substantial size of the cardiology application segment. The utilization of reprocessed devices in cardiology not only addresses the financial burden of procuring expensive single-use instruments but also aligns with the industry's shift towards sustainability.

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Hospitals dominate the market

Hospitals are at the forefront of sustainability efforts within the healthcare sector. With increased global awareness of environmental concerns, hospitals are under pressure to reduce their ecological footprint. Reprocessing single-use devices aligns perfectly with this sustainability objective by reducing the volume of medical waste generated. By reprocessing devices instead of disposing of them after a single use, hospitals contribute to waste reduction and minimize their impact on the environment. The adoption of reprocessed devices by hospitals also benefits from advancements in reprocessing technologies and the growing support from regulatory agencies. These factors collectively impel the credibility and safety of reprocessed devices, assuaging concerns about their efficacy. As hospitals focus to provide the best possible care to their patients, the assurance of regulatory compliance and technological sophistication plays a pivotal role in their decision to adopt reprocessed devices.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest single-use medical device reprocessing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America boasts an advanced and well-established healthcare infrastructure. The region is home to a plethora of world-renowned medical institutions, cutting-edge research centers, and innovative healthcare providers. This robust healthcare ecosystem naturally lends itself to the adoption of progressive medical practices, including the reprocessing of single-use devices. As a result, the market experiences a substantial influx of both demand and supply for reprocessed medical devices. Moreover, the stringent regulatory framework in North America serves as a catalyst for the adoption of safe and compliant reprocessing practices. Furthermore, the culture of innovation and technology adoption in North America contributes to the region's leadership in the market. Technological advancements in reprocessing techniques, sterilization methods, and quality control mechanisms are embraced more readily in this environment. Financial considerations also play a significant role in North America's dominance. The high costs associated with healthcare delivery, including the procurement of new medical devices, motivate healthcare institutions to explore cost-effective alternatives.

Competitive Landscape:

Companies are heavily investing in research and development to improve reprocessing techniques. This includes advancements in cleaning, disinfection, and sterilization methods to ensure that reprocessed devices meet or exceed regulatory requirements and maintain their safety and efficacy. Companies are also working closely with regulatory authorities to ensure that their reprocessed devices adhere to the necessary safety and quality standards. They engage in rigorous testing, validation, and documentation to demonstrate that reprocessed devices are equivalent to new ones in terms of performance and safety. Additionally, several companies are expanding their portfolios of reprocessed medical devices. Initially, the focus might have been on common devices, but as the market matures, companies are diversifying into more complex and specialized instruments used in various medical specialties. Moreover, companies are actively involved in educating healthcare professionals about the benefits and safety of reprocessed devices. This involves providing training sessions, workshops, webinars, and educational materials to ensure that healthcare providers have a clear understanding of the reprocessing process and the quality assurances in place.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Arjo Inc.

Innovative Health

Johnson & Johnson

Medline Industries LP

NEScientific Inc.

Steripro Canada

Stryker Corporation

SureTek Medical

Vanguard AG

Key Questions Answered in This Report

• 1. What was the size of the global single-use medical device reprocessing market in 2024?
• 2. What is the expected growth rate of the global single-use medical device reprocessing market during 2025-2033?
• 3. What are the key factors driving the global single-use medical device reprocessing market?
• 4. What has been the impact of COVID-19 on the global single-use medical device reprocessing market?
• 5. What is the breakup of the global single-use medical device reprocessing market based on the device type?
• 6. What is the breakup of the global single-use medical device reprocessing market based on the end user?
• 7. What are the key regions in the global single-use medical device reprocessing market?
• 8. Who are the key players/companies in the global single-use medical device reprocessing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Single-use Medical Device Reprocessing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Device Type

• 6.1 Class I Devices
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Laparoscopic Graspers
    • 6.1.2.2 Scalpels
    • 6.1.2.3 Tourniquet Cuffs
    • 6.1.2.4 Other Class I Devices
  • 6.1.3 Market Forecast
• 6.2 Class II Devices
  • 6.2.1 Market Trends
  • 6.2.2 Key Segments
    • 6.2.2.1 Pulse Oximeter Sensors
    • 6.2.2.2 Sequential Compression Sleeves
    • 6.2.2.3 Catheters and Guidewires
    • 6.2.2.4 Other Class II Devices
  • 6.2.3 Market Forecast

7 Market Breakup by Application

• 7.1 General Surgery
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Anesthesia
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Arthroscopy and Orthopaedic Surgery
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Cardiology
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Gastroenterology
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Gynaecology
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast
• 7.7 Urology
  • 7.7.1 Market Trends
  • 7.7.2 Market Forecast
• 7.8 Others
  • 7.8.1 Market Trends
  • 7.8.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Ambulatory Surgical Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Arjo Inc.
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 Innovative Health
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Johnson & Johnson
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Medline Industries LP
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 NEScientific Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Steripro Canada
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Stryker Corporation
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 SureTek Medical
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Vanguard AG
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio